Insider · CIK 0001691090

Feener Edward P.

Reports to the SEC for 1 company · SALISBURY, WILTSHIRE, X0

sec.gov

Transactions

Companies

Filings

CIK

0001691090

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-20	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−8,088 sh	$11.76	−$95.2K	72,858
2024-05-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+18.8K sh	—	—	80,946
2024-05-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,774 sh	—	—	14,190
2024-05-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,431 sh	—	—	14,583
2024-05-17	KalVista Pharmaceuticals, Inc.Performance Stock UnitsM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−7,292 sh	—	—	0
2024-05-17	KalVista Pharmaceuticals, Inc.Performance Stock UnitsM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−7,292 sh	—	—	14,583
2024-02-20	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−8,397 sh	$14.11	−$119K	82,048
2024-02-20	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−19.6K sh	$14.04	−$275K	62,457
2024-02-20	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−300 sh	$14.72	−$4,416	62,157
2024-02-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+18.8K sh	—	—	90,445
2024-02-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,774 sh	—	—	15,964
2024-02-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,430 sh	—	—	17,014
2024-02-17	KalVista Pharmaceuticals, Inc.Performance Stock UnitsM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−7,292 sh	—	—	7,292
2024-02-17	KalVista Pharmaceuticals, Inc.Performance Stock UnitsM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−7,292 sh	—	—	21,875
2024-02-14	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−28.2K sh	$15.01	−$423K	71,657
2024-02-11	KalVista Pharmaceuticals, Inc.A Award	CHIEF SCIENTIFIC OFFICER	AAward	+60K sh	—	—	99,828
2024-02-11	KalVista Pharmaceuticals, Inc.Performance Stock UnitsA Award	CHIEF SCIENTIFIC OFFICER	AAward	+29.2K sh	—	—	29,167
2024-01-11	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−22.7K sh	$13.03	−$296K	39,828
2024-01-09	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−100 sh	$13.00	−$1,300	62,507
2024-01-08	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−17.2K sh	$13.01	−$224K	62,607
2023-11-20	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−4,958 sh	$8.23	−$40.8K	79,828
2023-11-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+11.5K sh	—	—	84,786
2023-11-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,774 sh	—	—	17,738
2023-11-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,431 sh	—	—	19,444
2023-11-17	KalVista Pharmaceuticals, Inc.Performance Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−7,292 sh	—	—	0
2023-08-18	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−4,976 sh	$10.73	−$53.4K	73,289
2023-08-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+11.5K sh	—	—	78,265
2023-08-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,773 sh	—	—	19,512
2023-08-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,430 sh	—	—	21,875
2023-08-17	KalVista Pharmaceuticals, Inc.Performance Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−7,291 sh	—	—	0
2023-05-18	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−1,786 sh	$10.14	−$18.1K	66,771
2023-05-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+4,205 sh	—	—	68,557
2023-05-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,431 sh	—	—	24,305
2023-05-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,774 sh	—	—	21,285
2023-02-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+4,204 sh	—	—	66,580
2023-02-17	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,228 sh	$7.66	−$17.1K	64,352
2023-02-17	KalVista Pharmaceuticals, Inc.Performance Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,430 sh	—	—	0
2023-02-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,774 sh	—	—	23,059
2023-02-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,430 sh	—	—	26,736
2023-01-11	KalVista Pharmaceuticals, Inc.Restricted Stock UnitA Award	CHIEF SCIENTIFIC OFFICER	AAward	+29.2K sh	—	—	29,166
2022-11-18	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−530 sh	$5.44	−$2,883.2	62,376
2022-11-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+1,774 sh	—	—	62,906
2022-11-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,774 sh	—	—	24,833
2022-08-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+1,773 sh	—	—	61,664
2022-08-17	KalVista Pharmaceuticals, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−532 sh	$14.96	−$7,959.731	61,132
2022-08-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,773 sh	—	—	26,607
2022-05-17	KalVista Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+18.9K sh	—	—	18,920
2022-05-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitsA Award	CHIEF SCIENTIFIC OFFICER	AAward	+28.4K sh	—	—	28,380
2022-01-07	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+33.8K sh	$7.07	+$239K	36,034
2022-01-07	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+23.9K sh	$8.21	+$196K	59,891

Recent filings

Accepted (ET)
May 214
Feener Edward P.0001415889-24-014007
SEC(opens sec.gov)
Feb 214
Feener Edward P.0001415889-24-004718
SEC(opens sec.gov)
Feb 164
Feener Edward P.0001415889-24-004118
SEC(opens sec.gov)
Feb 134
Feener Edward P.0001415889-24-003483
SEC(opens sec.gov)
Jan 124
Feener Edward P.0001209191-24-001515
SEC(opens sec.gov)
Jan 104
Feener Edward P.0001209191-24-001391
SEC(opens sec.gov)

Companies

KalVista Pharmaceuticals, Inc.CHIEF SCIENTIFIC OFFICER

Address

C/O KALVISTA PHARMACEUTICALS, INC. BUILDING 227, TETRICUS SCIENCE PARK

SALISBURY, WILTSHIRE, X0, SP4 0JQ